This study aimed to investigate the effects of diode laser parameters on the thermal response and surface morphology of RBM (Resorbable Blast Media), SLA (Sandblasted, Large-grit, Acid-etched), and additively manufactured Ti6Al4V titanium surfaces, and to determine whether surface type influences heat distribution and integrity, which is clinically relevant in peri-implantitis treatment. A total of 144 titanium discs with three different surface treatments (RBM, SLA, and additively manufactured Ti6Al4V as the control group) were irradiated with a 940 nm diode laser at varying power levels (1 W, 2 W, 3 W), durations (30 s, 60 s), and modes (continuous, pulsed). Surface temperatures were recorded using thermal imaging. Morphological and elemental changes were evaluated via Scanning Electron Microscopy (SEM) and Energy-Dispersive X-ray Spectroscopy (EDS) analyses. A four-way Aligned Rank Transform Analysis of Variance (ART ANOVA) was used to analyze the effects of variables. Temperature increases were significantly influenced by all tested variables (p < 0.001). The RBM group exhibited the highest peak temperature (185 °C at 3 W pulsed mode, 60 s), while SLA surfaces consistently showed the lowest (39.9 °C at 1 W continius mode, 30 s). Pulsed mode and longer exposure times produced higher temperatures, except at 1 W, which resulted in the lowest temperature rise regardless of surface treatment. SEM images revealed mild surface alterations at higher power, with RBM exhibiting localized depressions and SLA displaying minor fragmentation of surface textures. EDS analysis indicated no major changes in elemental composition post-irradiation. The study highlights that different titanium surface types respond distinctly to diode laser irradiation, with RBM surfaces being more thermally reactive. Uniform laser protocols may not be appropriate for all implant surfaces. Careful consideration of power, duration, and surface characteristics is essential to avoid potential thermal damage during peri-implantitis treatment.
{"title":"Effects of diode laser parameters on thermal response of RBM, SLA, and additively manufactured titanium surfaces.","authors":"Ozlem Sarac Atagun, Ülkü Tuğba Kalyoncuoğlu, Bengi Yilmaz Erdemli, Simel Ayyildiz","doi":"10.1007/s10103-025-04759-3","DOIUrl":"10.1007/s10103-025-04759-3","url":null,"abstract":"<p><p>This study aimed to investigate the effects of diode laser parameters on the thermal response and surface morphology of RBM (Resorbable Blast Media), SLA (Sandblasted, Large-grit, Acid-etched), and additively manufactured Ti6Al4V titanium surfaces, and to determine whether surface type influences heat distribution and integrity, which is clinically relevant in peri-implantitis treatment. A total of 144 titanium discs with three different surface treatments (RBM, SLA, and additively manufactured Ti6Al4V as the control group) were irradiated with a 940 nm diode laser at varying power levels (1 W, 2 W, 3 W), durations (30 s, 60 s), and modes (continuous, pulsed). Surface temperatures were recorded using thermal imaging. Morphological and elemental changes were evaluated via Scanning Electron Microscopy (SEM) and Energy-Dispersive X-ray Spectroscopy (EDS) analyses. A four-way Aligned Rank Transform Analysis of Variance (ART ANOVA) was used to analyze the effects of variables. Temperature increases were significantly influenced by all tested variables (p < 0.001). The RBM group exhibited the highest peak temperature (185 °C at 3 W pulsed mode, 60 s), while SLA surfaces consistently showed the lowest (39.9 °C at 1 W continius mode, 30 s). Pulsed mode and longer exposure times produced higher temperatures, except at 1 W, which resulted in the lowest temperature rise regardless of surface treatment. SEM images revealed mild surface alterations at higher power, with RBM exhibiting localized depressions and SLA displaying minor fragmentation of surface textures. EDS analysis indicated no major changes in elemental composition post-irradiation. The study highlights that different titanium surface types respond distinctly to diode laser irradiation, with RBM surfaces being more thermally reactive. Uniform laser protocols may not be appropriate for all implant surfaces. Careful consideration of power, duration, and surface characteristics is essential to avoid potential thermal damage during peri-implantitis treatment.</p>","PeriodicalId":17978,"journal":{"name":"Lasers in Medical Science","volume":"40 1","pages":"511"},"PeriodicalIF":2.4,"publicationDate":"2025-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145668871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
This study aimed to evaluate the efficacy of low-level laser application in the treatment of periodontal intra-bony defects. Two independent reviewers conducted searches for articles published in English. The primary objective was to investigate whether clinical parameters improved in periodontal regeneration therapy with and without low-level laser therapy (LLLT). The primary outcome was probing depth (PD), while the secondary outcome measures were clinical attachment level (CAL), gingival recession (GR), and bone defect depth. After screening and eligibility assessment, eight studies were included in the analysis. For the primary outcome measure (PD), after sensitivity analysis, the reduction in PD from baseline to 3 months was greater in the laser group than in the non-laser group (P = 0.02). For the secondary outcome measure (CAL), after sensitivity analysis, the increase in CAL from baseline to 3 months was greater in the laser group (P < 0.001). Although laser therapy may be beneficial for early wound healing, the current evidence does not support its routine use in periodontal regenerative surgery. Further high-quality studies are warranted to evaluate its clinical efficacy.
{"title":"The application of low-level laser in the treatment of periodontal Intra-bony defects: systematic review and meta-analysis.","authors":"Yiru Wei, Ruonan Xu, Aishan Yilihamu, Yuting Chen, Gulinuer Awuti","doi":"10.1007/s10103-025-04767-3","DOIUrl":"10.1007/s10103-025-04767-3","url":null,"abstract":"<p><p>This study aimed to evaluate the efficacy of low-level laser application in the treatment of periodontal intra-bony defects. Two independent reviewers conducted searches for articles published in English. The primary objective was to investigate whether clinical parameters improved in periodontal regeneration therapy with and without low-level laser therapy (LLLT). The primary outcome was probing depth (PD), while the secondary outcome measures were clinical attachment level (CAL), gingival recession (GR), and bone defect depth. After screening and eligibility assessment, eight studies were included in the analysis. For the primary outcome measure (PD), after sensitivity analysis, the reduction in PD from baseline to 3 months was greater in the laser group than in the non-laser group (P = 0.02). For the secondary outcome measure (CAL), after sensitivity analysis, the increase in CAL from baseline to 3 months was greater in the laser group (P < 0.001). Although laser therapy may be beneficial for early wound healing, the current evidence does not support its routine use in periodontal regenerative surgery. Further high-quality studies are warranted to evaluate its clinical efficacy.</p>","PeriodicalId":17978,"journal":{"name":"Lasers in Medical Science","volume":"40 1","pages":"510"},"PeriodicalIF":2.4,"publicationDate":"2025-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12675631/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145668842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Purpose: To evaluate the clinical utility of endoscopic laser speckle contrast imaging (eLSCI) for intraoperative assessment of parathyroid gland (PTG) perfusion and functional preservation.
Methods: Fifteen patients undergoing unilateral/bilateral thyroidectomy at The Affiliated Lihuili Hospital of Ningbo University (November 2024 to April 2025) were prospectively enrolled. PTG perfusion was quantified using eLSCI by recording blood flow index (BFI) before and after thyroid resection. Serum parathyroid hormone (PTH) and calcium levels were measured preoperatively, at 15-min post-resection, and 24-h postoperatively. Pearson correlation analysis was used to assess the linear association between perfusion and functional parameters, while Spearman's rank correlation test was concurrently performed to verify the robustness.
Results: A significant correlation existed between the BFI change ratio and PTH change ratio at 15-min post-resection (r = 0.672, p = 0.006) and 24-h postoperatively (r = 0.671, p = 0.006). No significant correlation was observed between BFI change ratio and serum calcium change ratio at either timepoint (p > 0.05).
Conclusion: The eLSCI system enables real-time quantitative assessment of intraoperative parathyroid perfusion and demonstrates feasibility in predicting postoperative parathyroid function, holding significant potential for clinical application.
目的:探讨内镜下激光散斑造影(eLSCI)术中评估甲状旁腺(PTG)灌注及功能保存的临床应用价值。方法:前瞻性入选宁波大学附属丽丽丽医院于2024年11月至2025年4月行单侧/双侧甲状腺切除术的患者15例。采用eLSCI记录甲状腺切除术前后血流量指数(BFI),定量PTG灌注。术前、术后15分钟和术后24小时分别测定血清甲状旁腺激素(PTH)和钙水平。采用Pearson相关分析评估灌注与功能参数的线性相关性,同时采用Spearman秩相关检验验证稳健性。结果:术后15 min (r = 0.672, p = 0.006)和术后24 h (r = 0.671, p = 0.006) BFI变化率与PTH变化率存在显著相关性。各时间点BFI变化率与血钙变化率无显著相关性(p < 0.05)。结论:eLSCI系统能够实时定量评估术中甲状旁腺灌注,预测术后甲状旁腺功能具有可行性,具有重要的临床应用潜力。
{"title":"Endoscopic laser speckle imaging enables real-time prediction of parathyroid function in thyroidectomy.","authors":"Yingying Cui, Mengsha Zou, Baoan Song, Jiawei Tang, Jianan Zhang, Shang Shi, Gaoxiang Chen","doi":"10.1007/s10103-025-04760-w","DOIUrl":"10.1007/s10103-025-04760-w","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the clinical utility of endoscopic laser speckle contrast imaging (eLSCI) for intraoperative assessment of parathyroid gland (PTG) perfusion and functional preservation.</p><p><strong>Methods: </strong>Fifteen patients undergoing unilateral/bilateral thyroidectomy at The Affiliated Lihuili Hospital of Ningbo University (November 2024 to April 2025) were prospectively enrolled. PTG perfusion was quantified using eLSCI by recording blood flow index (BFI) before and after thyroid resection. Serum parathyroid hormone (PTH) and calcium levels were measured preoperatively, at 15-min post-resection, and 24-h postoperatively. Pearson correlation analysis was used to assess the linear association between perfusion and functional parameters, while Spearman's rank correlation test was concurrently performed to verify the robustness.</p><p><strong>Results: </strong>A significant correlation existed between the BFI change ratio and PTH change ratio at 15-min post-resection (r = 0.672, p = 0.006) and 24-h postoperatively (r = 0.671, p = 0.006). No significant correlation was observed between BFI change ratio and serum calcium change ratio at either timepoint (p > 0.05).</p><p><strong>Conclusion: </strong>The eLSCI system enables real-time quantitative assessment of intraoperative parathyroid perfusion and demonstrates feasibility in predicting postoperative parathyroid function, holding significant potential for clinical application.</p>","PeriodicalId":17978,"journal":{"name":"Lasers in Medical Science","volume":"40 1","pages":"508"},"PeriodicalIF":2.4,"publicationDate":"2025-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12672801/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145661449","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Gingival pigmentation is a common cosmetic concern that can negatively impact a patient's smile aesthetics. Laser-assisted depigmentation has emerged as a reliable and effective treatment modality. The study aimed to compare the efficacy, comfortability of the patient, and the post-operative outcomes among patients who underwent either an ablative or a non-ablative diode 450 nm laser for gingival depigmentation. A split-mouth, single-blind, randomized controlled trial was conducted on 20 subjects exhibiting physiological pigmentation scores of 2 or more, as assessed by the Dummett index. A diode laser emitting 450 nm wavelength was employed. One side of each subject's mouth was randomly assigned to receive ablative laser treatment, while the contralateral side received non-ablative treatment. Primary outcome measures included changes in Oral Pigmentation Index and Melanin Pigmentation Index scores at baseline and at 1, 6, and 12 months' post-treatment. Patient perception of pain and discomfort was assessed using a modified McGill Pain Questionnaire. Both ablative and non-ablative techniques demonstrated significant reductions in OPI and MPI scores at all follow-up time points. Immediate and total depigmentation was achieved using ablative techniques, which showed fewer rates of re-pigmentation but higher intraoperative discomfort. In contrast, non-ablative techniques result in less pain but required more sessions to obtain optimal results. The choice of technique should be individualized based on patient preferences and clinician expertise. Non-ablative treatment may be preferred for patients seeking minimal discomfort and rapid healing, while ablative treatment may be suitable for patients who prioritize complete pigment removal in one session.
{"title":"\"Laser assisted gingival melanin depigmentation using diode 450 nm; ablative vs. non-ablative techniques: randomized clinical trial\".","authors":"Walid Altayeb, Kenneth Luk, Josep Arnabat-Dominguez, Ahmed Abdullah, Raneem Darkazali, Omar Hamadah","doi":"10.1007/s10103-025-04762-8","DOIUrl":"10.1007/s10103-025-04762-8","url":null,"abstract":"<p><p>Gingival pigmentation is a common cosmetic concern that can negatively impact a patient's smile aesthetics. Laser-assisted depigmentation has emerged as a reliable and effective treatment modality. The study aimed to compare the efficacy, comfortability of the patient, and the post-operative outcomes among patients who underwent either an ablative or a non-ablative diode 450 nm laser for gingival depigmentation. A split-mouth, single-blind, randomized controlled trial was conducted on 20 subjects exhibiting physiological pigmentation scores of 2 or more, as assessed by the Dummett index. A diode laser emitting 450 nm wavelength was employed. One side of each subject's mouth was randomly assigned to receive ablative laser treatment, while the contralateral side received non-ablative treatment. Primary outcome measures included changes in Oral Pigmentation Index and Melanin Pigmentation Index scores at baseline and at 1, 6, and 12 months' post-treatment. Patient perception of pain and discomfort was assessed using a modified McGill Pain Questionnaire. Both ablative and non-ablative techniques demonstrated significant reductions in OPI and MPI scores at all follow-up time points. Immediate and total depigmentation was achieved using ablative techniques, which showed fewer rates of re-pigmentation but higher intraoperative discomfort. In contrast, non-ablative techniques result in less pain but required more sessions to obtain optimal results. The choice of technique should be individualized based on patient preferences and clinician expertise. Non-ablative treatment may be preferred for patients seeking minimal discomfort and rapid healing, while ablative treatment may be suitable for patients who prioritize complete pigment removal in one session.</p>","PeriodicalId":17978,"journal":{"name":"Lasers in Medical Science","volume":"40 1","pages":"509"},"PeriodicalIF":2.4,"publicationDate":"2025-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145668894","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-02DOI: 10.1007/s10103-025-04757-5
Poornima Chittabathina, Sruthima Nvs Gottumukkala, Gautami S Penmetsa, Ksv Ramesh, P Mohan Kumar, K Anil Kumar, M Gokul Nishanth
{"title":"Correction to: Clinical and microbiological outcomes of adjunctive photobiomodulation using various wavelengths in treatment of intrabony defects: a randomized controlled clinical trial.","authors":"Poornima Chittabathina, Sruthima Nvs Gottumukkala, Gautami S Penmetsa, Ksv Ramesh, P Mohan Kumar, K Anil Kumar, M Gokul Nishanth","doi":"10.1007/s10103-025-04757-5","DOIUrl":"10.1007/s10103-025-04757-5","url":null,"abstract":"","PeriodicalId":17978,"journal":{"name":"Lasers in Medical Science","volume":"40 1","pages":"505"},"PeriodicalIF":2.4,"publicationDate":"2025-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145654691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-02DOI: 10.1007/s10103-025-04758-4
Cristina Paixão Durães, Larissa Lopes Fonseca, Lorena Dos Reis Pereira Queiroz, Ricardo Santiago Gomez, Victor Hugo Dantas Guimarães, Sérgio Henrique Sousa Santos, Alfredo Maurício Batista de Paula, Lucyana Conceição Farias, André Luiz Sena Guimarães
{"title":"Photobiomodulation enhances radiosensitivity and suppresses oral squamous cell carcinoma in a 4NQO-induced mouse model.","authors":"Cristina Paixão Durães, Larissa Lopes Fonseca, Lorena Dos Reis Pereira Queiroz, Ricardo Santiago Gomez, Victor Hugo Dantas Guimarães, Sérgio Henrique Sousa Santos, Alfredo Maurício Batista de Paula, Lucyana Conceição Farias, André Luiz Sena Guimarães","doi":"10.1007/s10103-025-04758-4","DOIUrl":"10.1007/s10103-025-04758-4","url":null,"abstract":"","PeriodicalId":17978,"journal":{"name":"Lasers in Medical Science","volume":"40 1","pages":"507"},"PeriodicalIF":2.4,"publicationDate":"2025-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145654708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-02DOI: 10.1007/s10103-025-04750-y
Ghufran Abo Zaken, Marah Mhna Moussa, Muhammad Talaat Muhammad Nudar Albeik, Abdullah Omar, Samir Almahfoud
<p><p>Surgical excision remains the cornerstone treatment for skin cancer, considered the gold standard in clinical practice. However, alternative methods such as laser therapy are being explored for their potential to achieve tumor control while minimizing tissue damage and improving cosmetic outcomes. This review analyzes the existing literature on the use of Nd: YAG laser in the management of non-melanoma and melanoma skin cancer, with the aim of evaluating clearance and recurrence rates, as well as gaining deeper insights into the efficacy, safety, and potential side effects linked to this treatment approach. A systematic literature search was conducted using Embase, PubMed, Google Scholar, and Cochrane with the keywords: "Nd: YAG laser," "skin cancer," and "treatment." The search encompassed studies published from 1985 to July 2023 and included prospective, retrospective, double-blind randomized controlled trials, and non-blinded clinical trials in English. Studies were selected based on their focus on the use of Nd: YAG laser for non-melanoma including basal cell carcinoma and squamous cell carcinoma and melanoma skin cancer treatment, specifically excluding those that investigated the combination of ND: YAG laser with other therapies. Only studies reporting on the direct application of ND: YAG laser in treating various forms of skin cancer or premalignant skin lesions were considered for inclusion. Across all identified Nd: YAG laser studies from 1985 to 2023 (n = 12), a total of 7,358 histologically confirmed skin malignancies were reported, including 6,846 basal cell carcinomas (BCCs), 185 squamous cell carcinomas (SCCs), 323 malignant melanomas, and 4 cases of Bowen's disease. BCCs accounted for the vast majority of treated lesions (93.0%), followed by malignant melanoma (4.4%), SCC (2.5%), and Bowen's disease (0.05%). In calculating these totals, only lesions explicitly reported in each study were included. For instance, Brunner et al. (1985) described four patients with nevoid basal cell carcinoma syndrome as having "hundreds" of lesions; however, because the exact number was not provided, only the 200 histologically confirmed BCCs from this cohort were counted to avoid overestimation. No overlapping patients between studies were assumed unless explicitly noted. Moskalik et al. (2009) treated 188 recurrent limited BCCs alongside 3,346 primary BCCs, while Moskalik and Kozlow (2010) treated 172 recurrent limited BCCs within a cohort of 2,837 patients. El Tonsy et al. (2004) included patients with previously treated lesions, emphasizing the clearance of 37 BCCs, some of which were recurrent. Sharmazan et al. (1996) and later studies (Ortiz 2015/2018; Ahluwalia 2019; Markowitz & Bressler 2021; Kranz 2023) mostly treated primary BCCs but some non-facial and challenging anatomical locations likely included previously treated lesions. SCCs and melanomas were treated less frequently, usually in early-stage or thin lesions, and Bowen's disease
{"title":"Nd: YAG laser in the treatment of non-melanoma and melanoma skin cancers.","authors":"Ghufran Abo Zaken, Marah Mhna Moussa, Muhammad Talaat Muhammad Nudar Albeik, Abdullah Omar, Samir Almahfoud","doi":"10.1007/s10103-025-04750-y","DOIUrl":"10.1007/s10103-025-04750-y","url":null,"abstract":"<p><p>Surgical excision remains the cornerstone treatment for skin cancer, considered the gold standard in clinical practice. However, alternative methods such as laser therapy are being explored for their potential to achieve tumor control while minimizing tissue damage and improving cosmetic outcomes. This review analyzes the existing literature on the use of Nd: YAG laser in the management of non-melanoma and melanoma skin cancer, with the aim of evaluating clearance and recurrence rates, as well as gaining deeper insights into the efficacy, safety, and potential side effects linked to this treatment approach. A systematic literature search was conducted using Embase, PubMed, Google Scholar, and Cochrane with the keywords: \"Nd: YAG laser,\" \"skin cancer,\" and \"treatment.\" The search encompassed studies published from 1985 to July 2023 and included prospective, retrospective, double-blind randomized controlled trials, and non-blinded clinical trials in English. Studies were selected based on their focus on the use of Nd: YAG laser for non-melanoma including basal cell carcinoma and squamous cell carcinoma and melanoma skin cancer treatment, specifically excluding those that investigated the combination of ND: YAG laser with other therapies. Only studies reporting on the direct application of ND: YAG laser in treating various forms of skin cancer or premalignant skin lesions were considered for inclusion. Across all identified Nd: YAG laser studies from 1985 to 2023 (n = 12), a total of 7,358 histologically confirmed skin malignancies were reported, including 6,846 basal cell carcinomas (BCCs), 185 squamous cell carcinomas (SCCs), 323 malignant melanomas, and 4 cases of Bowen's disease. BCCs accounted for the vast majority of treated lesions (93.0%), followed by malignant melanoma (4.4%), SCC (2.5%), and Bowen's disease (0.05%). In calculating these totals, only lesions explicitly reported in each study were included. For instance, Brunner et al. (1985) described four patients with nevoid basal cell carcinoma syndrome as having \"hundreds\" of lesions; however, because the exact number was not provided, only the 200 histologically confirmed BCCs from this cohort were counted to avoid overestimation. No overlapping patients between studies were assumed unless explicitly noted. Moskalik et al. (2009) treated 188 recurrent limited BCCs alongside 3,346 primary BCCs, while Moskalik and Kozlow (2010) treated 172 recurrent limited BCCs within a cohort of 2,837 patients. El Tonsy et al. (2004) included patients with previously treated lesions, emphasizing the clearance of 37 BCCs, some of which were recurrent. Sharmazan et al. (1996) and later studies (Ortiz 2015/2018; Ahluwalia 2019; Markowitz & Bressler 2021; Kranz 2023) mostly treated primary BCCs but some non-facial and challenging anatomical locations likely included previously treated lesions. SCCs and melanomas were treated less frequently, usually in early-stage or thin lesions, and Bowen's disease","PeriodicalId":17978,"journal":{"name":"Lasers in Medical Science","volume":"40 1","pages":"506"},"PeriodicalIF":2.4,"publicationDate":"2025-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145654735","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
To evaluate and compare clinical outcomes, radiographic healing and regenerative biomarkers in laser-irradiated and non-irradiated groups undergoing regenerative endodontics in immature permanent teeth over a 12-month follow-up period. Twenty-eight patients with necrotic immature roots were assigned to one of two groups: a control group (n = 14) receiving standard regenerative endodontic procedure (REP) with a mock laser application, or an experimental group (n = 14) receiving standard REP with adjunctive low-level laser therapy (LLLT). Both groups underwent initial medication with double antibiotic paste. In the experimental group, a diode dental laser (810 nm, 4.5 J/cm², 0.3 W, 9 s) was applied to the apical third every 48 h for 14 days. After 21 days, intracanal bleeding was induced, and blood samples were collected for regenerative marker analysis using ELISA. Mineral trioxide aggregate was placed, followed by coronal restoration. Clinical symptoms and radiographic healing were monitored over 12 months, with statistical analysis performed using the independent t-test at a 95% confidence level. Clinically, both groups demonstrated high success rates (85.7% in the laser group vs. 78.6% in the control group; p = 0.83). No statistically significant differences were observed when pain and radiographic parameters were compared over time between the groups. Considering the biomarkers, only DSPP expression was significantly higher in the laser group (p = 0.03). For the other biomarkers (VEGF, TGF-β, MMP-8, PDGF-BB), the laser group showed numerically higher mean values, but these differences did not reach statistical significance (all p > 0.05). This study demonstrates that adjunctive low-level laser therapy (LLLT) during regenerative endodontic procedures produced comparable clinical and radiographic outcomes to standard treatment, with a significant increase in DSPP expression suggesting early molecular activation. While these findings indicate potential regenerative benefits, larger multicenter studies with extended follow-up are required to validate LLLT as an adjunct in clinical protocols. Trial registration: This trial was registered in the Clinical Trials Registry India (CTRI) under registration number CTRI/2024/01/062114 dated 31/01/2024.
{"title":"Clinical, radiographic, and biomarker perspectives of low-level laser therapy during regenerative endodontic procedures in necrotic immature young teeth: a randomized clinical study.","authors":"Pragya Pandey, Neha Jasrasaria, Ramesh Bharti, Rakesh Kumar Yadav, Monika Kumari, Abinia Vaishnavi, Rahul Pandey","doi":"10.1007/s10103-025-04764-6","DOIUrl":"10.1007/s10103-025-04764-6","url":null,"abstract":"<p><p>To evaluate and compare clinical outcomes, radiographic healing and regenerative biomarkers in laser-irradiated and non-irradiated groups undergoing regenerative endodontics in immature permanent teeth over a 12-month follow-up period. Twenty-eight patients with necrotic immature roots were assigned to one of two groups: a control group (n = 14) receiving standard regenerative endodontic procedure (REP) with a mock laser application, or an experimental group (n = 14) receiving standard REP with adjunctive low-level laser therapy (LLLT). Both groups underwent initial medication with double antibiotic paste. In the experimental group, a diode dental laser (810 nm, 4.5 J/cm², 0.3 W, 9 s) was applied to the apical third every 48 h for 14 days. After 21 days, intracanal bleeding was induced, and blood samples were collected for regenerative marker analysis using ELISA. Mineral trioxide aggregate was placed, followed by coronal restoration. Clinical symptoms and radiographic healing were monitored over 12 months, with statistical analysis performed using the independent t-test at a 95% confidence level. Clinically, both groups demonstrated high success rates (85.7% in the laser group vs. 78.6% in the control group; p = 0.83). No statistically significant differences were observed when pain and radiographic parameters were compared over time between the groups. Considering the biomarkers, only DSPP expression was significantly higher in the laser group (p = 0.03). For the other biomarkers (VEGF, TGF-β, MMP-8, PDGF-BB), the laser group showed numerically higher mean values, but these differences did not reach statistical significance (all p > 0.05). This study demonstrates that adjunctive low-level laser therapy (LLLT) during regenerative endodontic procedures produced comparable clinical and radiographic outcomes to standard treatment, with a significant increase in DSPP expression suggesting early molecular activation. While these findings indicate potential regenerative benefits, larger multicenter studies with extended follow-up are required to validate LLLT as an adjunct in clinical protocols. Trial registration: This trial was registered in the Clinical Trials Registry India (CTRI) under registration number CTRI/2024/01/062114 dated 31/01/2024.</p>","PeriodicalId":17978,"journal":{"name":"Lasers in Medical Science","volume":"40 1","pages":"504"},"PeriodicalIF":2.4,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145648835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
This study aimed to compare the efficacy of low-power laser therapy (LPLT) and low-frequency ultrasound (LFU) in reducing pain and improving quality of life in patients with diabetic polyneuropathy (DPN). A randomized controlled trial was conducted involving 55 patients with DPN, randomly assigned to three groups: LPLT (n = 18), LFU (n = 15), and control (n = 22). The LPLT group received treatments three times weekly for four weeks at 6 J/cm² using 808 nm and 905 nm wavelengths. The LFU group received treatments three times weekly for four weeks at 1 MHz, 0.5 W/cm², and 20% duty cycle. All interventions were administered alongside standard medical care. Baseline and post-intervention assessments included the Michigan Neuropathy Screening Instrument (MNSI) and Quality of Life in Diabetic Neuropathy (QOL-DN) measures. At baseline, significant differences were observed in patient-reported MNSI scores (p = 0.001), with the LPLT group reporting the highest scores. Post-intervention, all groups showed reductions in MNSI scores, but between-group differences were not significant (p = 0.292). The LPLT group exhibited the largest mean reduction (-2.39) in patient-reported MNSI scores, though the change only approached significance (p = 0.057). For QOL-DN, the LPLT group showed the greatest improvement in symptom scores (Mean=-2.55, p = 0.023) and problem scores (Mean=-7.05, p < 0.001). ANCOVA confirmed a significant group effect for QOL-DN problem scores (p = 0.007), with the LPLT group showing significantly greater improvement than controls (p = 0.006). LPLT may have potential for improving quality of life and neuropathy symptoms in DPN patients, but the limited between-group differences indicate that its clinical utility remains uncertain. Larger, multicenter trials with longer follow-up are needed to confirm these preliminary findings and establish clinical relevance.
{"title":"Effectiveness of low-power laser therapy and low-frequency ultrasound in reducing pain in patients with diabetic polyneuropathy: A randomized controlled trial.","authors":"Minoo Heidari Almasi, Nazanin Mosadeghi, Afsaneh Safarian, Pardis Heidari Almasi, Seyed Amirhossein Salehi, Zahra Ebrahimabadi, Soheila Sadeghi","doi":"10.1007/s10103-025-04720-4","DOIUrl":"10.1007/s10103-025-04720-4","url":null,"abstract":"<p><p>This study aimed to compare the efficacy of low-power laser therapy (LPLT) and low-frequency ultrasound (LFU) in reducing pain and improving quality of life in patients with diabetic polyneuropathy (DPN). A randomized controlled trial was conducted involving 55 patients with DPN, randomly assigned to three groups: LPLT (n = 18), LFU (n = 15), and control (n = 22). The LPLT group received treatments three times weekly for four weeks at 6 J/cm² using 808 nm and 905 nm wavelengths. The LFU group received treatments three times weekly for four weeks at 1 MHz, 0.5 W/cm², and 20% duty cycle. All interventions were administered alongside standard medical care. Baseline and post-intervention assessments included the Michigan Neuropathy Screening Instrument (MNSI) and Quality of Life in Diabetic Neuropathy (QOL-DN) measures. At baseline, significant differences were observed in patient-reported MNSI scores (p = 0.001), with the LPLT group reporting the highest scores. Post-intervention, all groups showed reductions in MNSI scores, but between-group differences were not significant (p = 0.292). The LPLT group exhibited the largest mean reduction (-2.39) in patient-reported MNSI scores, though the change only approached significance (p = 0.057). For QOL-DN, the LPLT group showed the greatest improvement in symptom scores (Mean=-2.55, p = 0.023) and problem scores (Mean=-7.05, p < 0.001). ANCOVA confirmed a significant group effect for QOL-DN problem scores (p = 0.007), with the LPLT group showing significantly greater improvement than controls (p = 0.006). LPLT may have potential for improving quality of life and neuropathy symptoms in DPN patients, but the limited between-group differences indicate that its clinical utility remains uncertain. Larger, multicenter trials with longer follow-up are needed to confirm these preliminary findings and establish clinical relevance.</p>","PeriodicalId":17978,"journal":{"name":"Lasers in Medical Science","volume":"40 1","pages":"503"},"PeriodicalIF":2.4,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145648829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-29DOI: 10.1007/s10103-025-04746-8
Kwangchon Ko, Hye Guk Ryu, Jinyoung Park, Wanil Kim, Sangjune Kim, Jeongah Ko, Sung Bin Cho
Monopolar radiofrequency (RF) devices are widely used for skin tightening, wrinkle reduction, and body contouring. However, frequency-dependent differences in energy absorption and tissue remodeling remain insufficiently characterized. This study aimed to compare the thermal distribution and histological responses induced by 6.78‑ and 2‑MHz monopolar RF, as well as their sequential combination. Finite-element computational modeling was used to simulate electric field propagation and heat diffusion in multilayered skin with varying subcutaneous fat thicknesses and fibrous septa configurations. In vivo experiments were conducted on porcine skin treated with 6.78‑, 2‑, and dual‑frequency RF modes. Histologic changes were evaluated using hematoxylin and eosin, Masson's trichrome, and Verhoeff-van Gieson staining. Apoptotic cell death was assessed using the terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay to evaluate adipocyte viability. Computational modeling demonstrated that 2‑MHz RF produced broader and deeper thermal effects within the adipose tissue, whereas 6.78‑MHz RF generated more localized heating along the fibrous septa. Dual-frequency RF combines these effects, creating pronounced thermal reactions at the dermosubcutaneous junction. Histological analysis revealed significant collagen and elastin remodeling across the dermis and fibrous septa in dual-frequency-treated specimens, with no evidence of adipocyte apoptosis. Moreover, remodeling changes were more extensive and persistent at later time points, suggesting that dual-frequency treatments have a greater tissue remodeling potential compared with single-frequency applications. Dual-frequency monopolar RF effectively promoted extracellular matrix remodeling in the dermis and subcutis while preserving adipocyte viability, suggesting its use as a safe and versatile modality for skin rejuvenation and contouring.
{"title":"Computational modeling and histologic analysis of 6.78- and 2-MHz monopolar radiofrequency-induced thermal reactions.","authors":"Kwangchon Ko, Hye Guk Ryu, Jinyoung Park, Wanil Kim, Sangjune Kim, Jeongah Ko, Sung Bin Cho","doi":"10.1007/s10103-025-04746-8","DOIUrl":"10.1007/s10103-025-04746-8","url":null,"abstract":"<p><p>Monopolar radiofrequency (RF) devices are widely used for skin tightening, wrinkle reduction, and body contouring. However, frequency-dependent differences in energy absorption and tissue remodeling remain insufficiently characterized. This study aimed to compare the thermal distribution and histological responses induced by 6.78‑ and 2‑MHz monopolar RF, as well as their sequential combination. Finite-element computational modeling was used to simulate electric field propagation and heat diffusion in multilayered skin with varying subcutaneous fat thicknesses and fibrous septa configurations. In vivo experiments were conducted on porcine skin treated with 6.78‑, 2‑, and dual‑frequency RF modes. Histologic changes were evaluated using hematoxylin and eosin, Masson's trichrome, and Verhoeff-van Gieson staining. Apoptotic cell death was assessed using the terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay to evaluate adipocyte viability. Computational modeling demonstrated that 2‑MHz RF produced broader and deeper thermal effects within the adipose tissue, whereas 6.78‑MHz RF generated more localized heating along the fibrous septa. Dual-frequency RF combines these effects, creating pronounced thermal reactions at the dermosubcutaneous junction. Histological analysis revealed significant collagen and elastin remodeling across the dermis and fibrous septa in dual-frequency-treated specimens, with no evidence of adipocyte apoptosis. Moreover, remodeling changes were more extensive and persistent at later time points, suggesting that dual-frequency treatments have a greater tissue remodeling potential compared with single-frequency applications. Dual-frequency monopolar RF effectively promoted extracellular matrix remodeling in the dermis and subcutis while preserving adipocyte viability, suggesting its use as a safe and versatile modality for skin rejuvenation and contouring.</p>","PeriodicalId":17978,"journal":{"name":"Lasers in Medical Science","volume":"40 1","pages":"501"},"PeriodicalIF":2.4,"publicationDate":"2025-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12662868/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145635198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}